GSK1904529A

Chemical Compounds

貨號 Cat. No.
M1717
規格 Size
5mg,10mg,50mg
品牌 Brand
No Brand

Description

GSK1904529A, selectively inhibits IGF-IR and IR with IC50s of 27 and 25 nmol/L, respectively. It is a promising candidate for therapeutic use in solid and hematologic cancers. IC50s for GSK1904529A in tumor cell lines ranged from 35 nmol/L to >30 umol/L. The tumor histologic types showing the greatest sensitivity to this compound were Ewing’s sarcoma and multiple myeloma, where IC50s in three of five Ewing’s sarcoma cell lines were

詢價 / 洽詢此產品 下載 PDF

同品牌其他產品

回到產品列表

▲ LINE
諮詢